Drug Shortage Report for VAQTA

Last updated on 2022-05-11 History
Report ID 157166
Drug Identification Number 02229702
Brand name VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 25U/0.5ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-05-02
Actual start date 2022-04-07
Estimated end date 2022-05-31
Actual end date 2022-05-10
Shortage status Resolved
Updated date 2022-05-11
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2022-05-11 English Compare
v18 2022-05-10 French Compare
v17 2022-05-10 English Compare
v16 2022-04-08 English Compare
v15 2022-04-07 French Compare
v14 2022-04-07 English Compare
v13 2022-04-07 English Compare
v12 2022-04-07 English Compare
v11 2022-04-07 English Compare
v10 2022-04-07 French Compare
v9 2022-04-07 English Compare
v8 2022-03-29 French Compare
v7 2022-03-29 English Compare
v6 2022-03-24 French Compare
v5 2022-03-24 English Compare
v4 2022-03-23 French Compare
v3 2022-03-23 English Compare
v2 2022-03-23 French Compare
v1 2022-03-23 English Compare

Showing 1 to 19 of 19